Another Three Centers Under the French Unicancer Framework Select RayStation
Another Three Centers Under the French Unicancer Framework Select RayStation
In total, 14 centers, out of the 20 centers that constitute the Unicancer network, as well as two public hospitals, have purchased RayStation under the Unicancer 2019/PPE019 Framework agreements (four years). RayStation and RayCare have now been selected in a new Unicancer Framework agreement (2023), which applies from STOCKHOLM, Oct. 16, 2024 /PRNewswire/ -- RaySearch Laboratories AB (publ) is pleased to announce that Institut de Cancérologie de Lorraine, Centre Jean Perrin, and Centre Hospitalier Universitaire de Limoges, have placed orders for the treatment planning system RayStation* under the Unicancer 2019 Framework agreement.
RaySearch Laboratories Ab（ 公開公司）於 2024 年 10 月 16 日在斯德哥爾摩宣佈，洛林癌症研究所、讓·佩蘭中心和利摩日大學醫院已根據 Unicancer 2019 框架協議訂購了治療計劃系統 RayStation*。
Unicancer is a French hospital network exclusively specialized in oncology. It brings together 18 comprehensive cancer centers and two affiliated centers, spread across 22 hospitals in France. Annually, more than 600,000 patients are treated at a Unicancer center and across the network, 787 clinical trials are ongoing.
Unicancer 是一個專門從事腫瘤學的法國醫院網絡，彙集了 18 家綜合癌症中心和兩家附屬中心，遍佈法國的 22 家醫院。每年，有超過 600,000 名患者在 Unicancer 中心接受治療，整個網絡中有 787 個臨床試驗正在進行。
The orders from Institut de Cancérologie de Lorraine, Centre Jean Perrin, and Centre Hospitalier Universitaire de Limoges were received during the summer of 2024. The total order value from the three sites was 3.2 MEUR excluding service contracts, of which about one third was recognized as revenue in Q2 and two thirds in Q3.
洛林癌症研究所、讓·佩蘭中心和利摩日大學醫院在 2024 年夏季下訂單。這三個地點的總訂單價值爲 3.2 百萬歐元（不包括服務合同），其中約三分之一的營業收入在 Q2 中確認，而三分之二在 Q3 中確認。
In total, 14 centers, out of the 20 centers that constitute the Unicancer network, as well as two public hospitals, have purchased RayStation under the Unicancer 2019/PPE019 Framework agreements (four years). RayStation and RayCare have now been selected in a new Unicancer Framework agreement (2023), which applies from August 2024.
共有 14 箇中心，共 20 個組成 Unicancer 網絡的中心以及兩家公立醫院在 Unicancer 2019/PPE019 框架協議（四年）下購買了 RayStation。RayStation 和 RayCare 現已在新的 Unicancer 框架協議（2023 年）中被選中，在 2024 年 8 月起生效。
Johan Löf, Founder and CEO, RaySearch: "I am very happy about the agreements with these important French centers, especially since they are all comprehensive cancer centers. RayStation is an excellent starting point, but our vision is that our software should support all the disciplines included in a comprehensive cancer center."
RaySearch 的創始人兼首席執行官 Johan Löf 表示：「我對與這些重要的法國中心達成協議感到非常高興，尤其是它們都是綜合癌症中心。RayStation 是一個很好的起點，但我們的願景是，我們的軟件應該支持綜合癌症中心中涵蓋的所有學科。」
* Subject to regulatory clearance in some markets.
* 在一些市場上需要獲得監管批准。
FOR MORE INFORMATION, PLEASE CONTACT:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
[email protected]
如需更多資訊，請聯繫：
Johan Löf，創始人兼首席執行官，RaySearch Laboratories Ab (publ)
電話：+46 (0) 8 510 530 00
[email protected]
Learn more about us on:
LinkedIn
YouTube
了解更多關於我們的信息：
LinkedIn
YouTube
This information was brought to you by Cision
本信息由Cision提供
The following files are available for download:
以下文件可供下載：
|
RaySearch Press Release October 16, 2024 |
|
|
Press-release 1200x620 Unicancer |
|
RaySearch 2024年10月16日新聞發佈 |
|
|
新聞發佈 1200x620 Unicancer |
SOURCE RaySearch Laboratories
來源： RaySearch Laboratories
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
想要您公司的新聞在PRNEWSWIRE.COM上特色呈現嗎？
